mRNA-From COVID-19 Treatment to Cancer Immunotherapy.
Biomedicines
; 11(2)2023 Jan 22.
Article
in English
| MEDLINE | ID: covidwho-2267211
ABSTRACT
This review provides an overview covering mRNA from its use in the COVID-19 pandemic to cancer immunotherapy, starting from the selection of appropriate antigens, tumor-associated and tumor-specific antigens, neoantigens, the basics of optimizing the mRNA molecule in terms of stability, efficacy, and tolerability, choosing the best formulation and the optimal route of administration, to summarizing current clinical trials of mRNA vaccines in tumor therapy.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Prognostic study
Topics:
Vaccines
Language:
English
Year:
2023
Document Type:
Article
Affiliation country:
Biomedicines11020308
Similar
MEDLINE
...
LILACS
LIS